117 related articles for article (PubMed ID: 10571408)
1. Increased SPARC expression promotes U87 glioblastoma invasion in vitro.
Golembieski WA; Ge S; Nelson K; Mikkelsen T; Rempel SA
Int J Dev Neurosci; 1999; 17(5-6):463-72. PubMed ID: 10571408
[TBL] [Abstract][Full Text] [Related]
2. Secreted protein acidic and rich in cysteine promotes glioma invasion and delays tumor growth in vivo.
Schultz C; Lemke N; Ge S; Golembieski WA; Rempel SA
Cancer Res; 2002 Nov; 62(21):6270-7. PubMed ID: 12414657
[TBL] [Abstract][Full Text] [Related]
3. cDNA array analysis of SPARC-modulated changes in glioma gene expression.
Golembieski WA; Rempel SA
J Neurooncol; 2002 Dec; 60(3):213-26. PubMed ID: 12510773
[TBL] [Abstract][Full Text] [Related]
4. SPARC modulates cell growth, attachment and migration of U87 glioma cells on brain extracellular matrix proteins.
Rempel SA; Golembieski WA; Fisher JL; Maile M; Nakeff A
J Neurooncol; 2001 Jun; 53(2):149-60. PubMed ID: 11716067
[TBL] [Abstract][Full Text] [Related]
5. SPARC: a signal of astrocytic neoplastic transformation and reactive response in human primary and xenograft gliomas.
Rempel SA; Golembieski WA; Ge S; Lemke N; Elisevich K; Mikkelsen T; Gutiérrez JA
J Neuropathol Exp Neurol; 1998 Dec; 57(12):1112-21. PubMed ID: 9862633
[TBL] [Abstract][Full Text] [Related]
6. HSP27 mediates SPARC-induced changes in glioma morphology, migration, and invasion.
Golembieski WA; Thomas SL; Schultz CR; Yunker CK; McClung HM; Lemke N; Cazacu S; Barker T; Sage EH; Brodie C; Rempel SA
Glia; 2008 Aug; 56(10):1061-75. PubMed ID: 18442089
[TBL] [Abstract][Full Text] [Related]
7. SPARC affects glioma cell growth differently when grown on brain ECM proteins in vitro under standard versus reduced-serum stress conditions.
Vadlamuri SV; Media J; Sankey SS; Nakeff A; Divine G; Rempel SA
Neuro Oncol; 2003 Oct; 5(4):244-54. PubMed ID: 14565160
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of SPARC expression inhibits cell migration and invasion in malignant gliomas.
Seno T; Harada H; Kohno S; Teraoka M; Inoue A; Ohnishi T
Int J Oncol; 2009 Mar; 34(3):707-15. PubMed ID: 19212676
[TBL] [Abstract][Full Text] [Related]
9. Integrin β4 regulates SPARC protein to promote invasion.
Gerson KD; Shearstone JR; Maddula VSRK; Seligmann BE; Mercurio AM
J Biol Chem; 2012 Mar; 287(13):9835-9844. PubMed ID: 22308039
[TBL] [Abstract][Full Text] [Related]
10. SPARC-induced migration of glioblastoma cell lines via uPA-uPAR signaling and activation of small GTPase RhoA.
Kunigal S; Gondi CS; Gujrati M; Lakka SS; Dinh DH; Olivero WC; Rao JS
Int J Oncol; 2006 Dec; 29(6):1349-57. PubMed ID: 17088972
[TBL] [Abstract][Full Text] [Related]
11. Expression of SPARC is correlated with altered morphologies in transfected F9 embryonal carcinoma cells.
Everitt EA; Sage EH
Exp Cell Res; 1992 Mar; 199(1):134-46. PubMed ID: 1310471
[TBL] [Abstract][Full Text] [Related]
12. SPARC promotes cathepsin B-mediated melanoma invasiveness through a collagen I/α2β1 integrin axis.
Girotti MR; Fernández M; López JA; Camafeita E; Fernández EA; Albar JP; Benedetti LG; Valacco MP; Brekken RA; Podhajcer OL; Llera AS
J Invest Dermatol; 2011 Dec; 131(12):2438-47. PubMed ID: 21850018
[TBL] [Abstract][Full Text] [Related]
13. Doxycycline-inducible expression of SPARC/Osteonectin/BM40 in MDA-MB-231 human breast cancer cells results in growth inhibition.
Dhanesuan N; Sharp JA; Blick T; Price JT; Thompson EW
Breast Cancer Res Treat; 2002 Sep; 75(1):73-85. PubMed ID: 12500936
[TBL] [Abstract][Full Text] [Related]
14. SPARC upregulates MT1-MMP expression, MMP-2 activation, and the secretion and cleavage of galectin-3 in U87MG glioma cells.
McClung HM; Thomas SL; Osenkowski P; Toth M; Menon P; Raz A; Fridman R; Rempel SA
Neurosci Lett; 2007 May; 419(2):172-7. PubMed ID: 17490812
[TBL] [Abstract][Full Text] [Related]
15. SPARC Expression Is Selectively Suppressed in Tumor Initiating Urospheres Isolated from As+3- and Cd+2-Transformed Human Urothelial Cells (UROtsa) Stably Transfected with SPARC.
Slusser-Nore A; Larson-Casey JL; Zhang R; Zhou XD; Somji S; Garrett SH; Sens DA; Dunlevy JR
PLoS One; 2016; 11(1):e0147362. PubMed ID: 26783756
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional upregulation of SPARC, in response to c-Jun overexpression, contributes to increased motility and invasion of MCF7 breast cancer cells.
Briggs J; Chamboredon S; Castellazzi M; Kerry JA; Bos TJ
Oncogene; 2002 Oct; 21(46):7077-91. PubMed ID: 12370830
[TBL] [Abstract][Full Text] [Related]
17. Improved response to nab-paclitaxel compared with cremophor-solubilized paclitaxel is independent of secreted protein acidic and rich in cysteine expression in non-small cell lung cancer.
Shao H; Tang H; Salavaggione OE; Yu C; Hylander B; Tan W; Repasky E; Adjei AA; Dy GK
J Thorac Oncol; 2011 Jun; 6(6):998-1005. PubMed ID: 21532503
[TBL] [Abstract][Full Text] [Related]
18. Effect of Ukrain on matrix metalloproteinase-2 and Secreted Protein Acidic and Rich in Cysteine (SPARC) expression in human glioblastoma cells.
Gagliano N; Moscheni C; Torri C; Magnani I; Bertelli AA; Nowicky W; Gioia M
Anticancer Drugs; 2006 Feb; 17(2):189-94. PubMed ID: 16428937
[TBL] [Abstract][Full Text] [Related]
19. SPARC represses E-cadherin and induces mesenchymal transition during melanoma development.
Robert G; Gaggioli C; Bailet O; Chavey C; Abbe P; Aberdam E; Sabatié E; Cano A; Garcia de Herreros A; Ballotti R; Tartare-Deckert S
Cancer Res; 2006 Aug; 66(15):7516-23. PubMed ID: 16885349
[TBL] [Abstract][Full Text] [Related]
20. Targeting SPARC expression decreases glioma cellular survival and invasion associated with reduced activities of FAK and ILK kinases.
Shi Q; Bao S; Song L; Wu Q; Bigner DD; Hjelmeland AB; Rich JN
Oncogene; 2007 Jun; 26(28):4084-94. PubMed ID: 17213807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
